Resmed Inc DRC Valuation
| RSMDFDelisted Stock | USD 17.70 0.00 0.00% |
At this time, the company appears to be overvalued. Resmed Inc DRC holds a recent Real Value of $15.04 per share. The prevailing price of the company is $17.7. Our model determines the value of Resmed Inc DRC from analyzing the company fundamentals such as Return On Equity of 0.24, shares outstanding of 1.47 B, and Operating Margin of 0.28 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Resmed's price fluctuation is very steady at this time. Calculation of the real value of Resmed Inc DRC is based on 3 months time horizon. Increasing Resmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Resmed pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Resmed Inc DRC. Since Resmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Resmed Pink Sheet. However, Resmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.7 | Real 15.04 | Hype 17.7 | Naive 17.7 |
The real value of Resmed Pink Sheet, also known as its intrinsic value, is the underlying worth of Resmed Inc DRC Company, which is reflected in its stock price. It is based on Resmed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Resmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Resmed Inc DRC helps investors to forecast how Resmed pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Resmed more accurately as focusing exclusively on Resmed's fundamentals will not take into account other important factors: Resmed Total Value Analysis
Resmed Inc DRC is at this time forecasted to have takeover price of 33.08 B with market capitalization of 34.16 B, debt of 765.33 M, and cash on hands of 273.71 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Resmed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.08 B | 34.16 B | 765.33 M | 273.71 M |
Resmed Investor Information
The company has Price/Earnings To Growth (PEG) ratio of 1.76. Resmed Inc DRC last dividend was issued on the 8th of February 2023. The entity had 2:1 split on the 31st of August 2010. Based on the measurements of operating efficiency obtained from Resmed's historical financial statements, Resmed Inc DRC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Resmed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Resmed has an asset utilization ratio of 70216.45 percent. This implies that the Company is making $702.16 for each dollar of assets. An increasing asset utilization means that Resmed Inc DRC is more efficient with each dollar of assets it utilizes for everyday operations.Resmed Ownership Allocation
Resmed owns a total of 1.47 Billion outstanding shares. Roughly 92.07 pct. of Resmed outstanding shares are held by general public with 7.94 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Resmed Profitability Analysis
The company reported the revenue of 3.58 B. Net Income was 779.44 M with profit before overhead, payroll, taxes, and interest of 2.06 B.Resmed Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Resmed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Resmed and how it compares across the competition.
About Resmed Valuation
The pink sheet valuation mechanism determines Resmed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Resmed. We calculate exposure to Resmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Resmed's related companies.ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Resmed Inc operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8160 people.
8 Steps to conduct Resmed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Resmed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Resmed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Resmed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Resmed's revenue streams: Identify Resmed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Resmed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Resmed's growth potential: Evaluate Resmed's management, business model, and growth potential.
- Determine Resmed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Resmed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Resmed represents a small ownership stake in the entity. As a stockholder of Resmed, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Resmed Dividends Analysis For Valuation
Please note that Resmed has scaled down on payment of dividends at this time.
There are various types of dividends Resmed can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Resmed shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Resmed Inc DRC directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Resmed pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Resmed by the value of the dividends paid out.
Resmed Growth Indicators
Investing in growth stocks can be very risky. If the company such as Resmed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 147 M | |
| Quarterly Earnings Growth Y O Y | 0.117 | |
| Forward Price Earnings | 35.7143 | |
| Retained Earnings | 3.6 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |